The role and therapeutic potential of GLP-1 analogues as a treatment for type 2 diabetes

The role and therapeutic potential of GLP-1 analogues as a treatment for type 2 diabetes

Bibliographic Details
Main Author:	Lavery, Kerry Susan
Published:	University of Ulster 2006
Subjects:	615
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.494366

Similar Items

Polymorphisms of GLP-1 Receptor Gene and Response to GLP-1 Analogue in Patients with Poorly Controlled Type 2 Diabetes
by: Chia-Hung Lin, et al.
Published: (2015-01-01)

GLP-1 and muscarinic receptor mediated activation of ERK1/2 in pancreatic β-cells
by: Selway, Joanne Louise
Published: (2010)

Analogues of Dicoumarol as Inhibitors of NQO1
by: Scott, Katherine Ann
Published: (2010)

Neuroprotective effect of GLP-1 receptor agonist Exendin-4 in rat models of Parkinson's disease
by: Harkavyi, Alexander
Published: (2009)

Purslane Effect on GLP-1 and GLP-1 receptor in type 2 diabetes
by: Sara Heidarzadeh, et al.
Published: (2013-01-01)

Purslane Effect on GLP-1 and GLP-1 receptor in type 2 diabetes
by: Roja Daliri, et al.
Published: (2013-01-01)

Synthesis of analogues of quindoline as potential telomerase inhibitors
by: Guyen, B.
Published: (2003)

The potential therapeutic role of selenium in diffuse large B-cell lymphoma
by: Kassam, Shireen
Published: (2011)

Dual GIP–GLP1-Receptor Agonists In The Treatment Of Type 2 Diabetes: A Short Review On Emerging Data And Therapeutic Potential
by: Bastin M, et al.
Published: (2019-09-01)

Emerging technologies to achieve oral delivery of GLP-1 and GLP-1 analogs for treatment of type 2 diabetes mellitus (T2DM)
by: Shengwu Ma, et al.
Published: (2017-04-01)

Synthesis and evaluation of narciclasine analogues
by: Judd, Katie
Published: (2011)

The functionalisation of 2-azanorbornanes and approaches to novel epidatidine analogues
by: White, Richard
Published: (2006)

N-methylated Peptides for the treatment of Alzheimer's Disease and Type II Diabetes
by: Kokkoni, Nicoleta
Published: (2004)

GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art
by: Michael A. Nauck, et al.
Published: (2021-04-01)

Characterisation of small protease inhibitors as potential therapeutics
by: McCrudden, Maeliosa Theresa Christine
Published: (2008)

Synthesis of Kanamycin analogues
by: Martinez-Tobed, A.
Published: (1977)

Synthesis and Evaluation of Optical and PET GLP-1 Peptide Analogues for GLP-1R Imaging
by: Babak Behnam Azad, et al.
Published: (2015-01-01)

Experimental Studies on the Role of Specific Dopamine Receptors in the Cardiovascular Actions of Dopamine and Analogues
by: Al-Jeboory, A. A.
Published: (1978)

The synthesis of novel 6-azapyrimidine nucleoside analogues
by: Jasamai, Malina
Published: (2006)

Design and synthesis of novel PPAR agonists for the treatment of the metabolic syndrome and diabetes type II
by: Bhurruth, Anju Hina Yushma
Published: (2007)

Study of Motivational Interviewing in adolescents with type 1 diabetes
by: Huws-Thomas, Michelle Victoria
Published: (2007)

Actions and antidiabetic potential of amino terminally modified analogues of glucose dependent insulinotropic polypeptide
by: Gault, Victor Alan
Published: (2001)

Metabolic effects of combining American ginseng (Panax quinquefolius L.) and viscous fibre in the treatment of type 2 diabetes
by: Jenkins, Alexandra Louisa
Published: (2005)

The synthesis of morphine-6-glucuronide analogues as potential analgesics
by: Di Pretoro, Anna M. A.
Published: (1996)

Novel potential peptide therapeutics for tuberculosis therapy
by: Scotti, F.
Published: (2017)

The synthesis of novel anticancer agents with therapeutic potential
by: Ganeshapillai, Dharshini
Published: (2001)

Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UK
by: Kristina S. Boye, et al.
Published: (2019-05-01)

Synthesis and biological assays at the D2 dopamine receptor of suramin and suramin analogues
by: Meneveau-Cardonnel, Caroline
Published: (2009)

2-Hydroxybenzoate analogue mediated apoptosis in human HT-1080 fibrosarcoma cells
by: Alkarrawi, Mohammed
Published: (2005)

Design, synthesis and biological evaluation of novel analogues of Distamycin
by: Brucoli, Federico
Published: (2009)

The development of pancreatic polypeptide analogues as a pharmacotherapy for obesity
by: Baxter, Jordan Eleanor
Published: (2011)

The synthesis and structure-activity relations of some benzomorphan analogues
by: O''Sullivan, J.
Published: (1973)

Inhibition of GIP signalling alleviates obesity, insulin resistance and type 2 diabetes
by: McClean, Paula
Published: (2007)

Design, synthesis and SAR studies of pyridine dicarbonitriles as potential prion therapeutics
by: Reddy, Tummala Ramakrishna
Published: (2006)

Comparison of GLP-1 analogues versus sitagliptin in the management of type 2 diabetes: systematic review and meta-analysis of head-to-head studies.
by: Tiansheng Wang, et al.
Published: (2014-01-01)

Synthesis of carbocyclic nucleoside and nucleotide analogues as potential antiviral agents
by: Coe, Diane Mary
Published: (1991)

Synthetic studies on novel bryostatin analogues and their interaction with the CRD2 of protein kinase C
by: Frigerio, Mark
Published: (2004)

The mechanisms underlying the anti-cancer activity of substance-P analogues
by: Waters, Catherine M.
Published: (2001)

Genetic modification of human mesenchymal stem cells using HSV-1 amplicons to improve their therapeutic potential
by: El-Sherbini, Yasser Mahmoud
Published: (2009)

Selecting GLP-1 agonists in the management of type 2 diabetes: differential pharmacology and therapeutic benefits of liraglutide and exenatide
by: Jonathan Pinkney, et al.
Published: (2010-08-01)